Company attributes
Industry
Location
B2X
CEO
Legal Name
Cellino Biotech, Inc.
Legal classification
Number of Employees (Ranges)
51 – 2000
Email Address
connect@cellinobio.com0
partner@cellinobio.com0
Full Address
501 Massachusetts Ave, Cambridge, Massachusetts, 02139, United States0
Investors
Founded Date
2017
0Total Funding Amount (USD)
93,100,000
Latest Funding Round Date
January 25, 2022
Also Known As
Cellino Biotech
Latest Funding Type
Patents Assigned (Count)
1
Country
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
80,000,000
Cellino is an autologous regenerative medicine company that develops an AI-based single-cell laser editing platform for cell-based therapies. It has developed a platform that automates and standardizes autologous stem cell production.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.